In a clinical observational cohort study examining NT-proBNP and echocardiography in 74 patients undergoing chemotherapy for breast cancer, there was a strong association between increased NT-proBNP levels and decreased LV-GLS in identifying cardiotoxicity. This evidence concerns the gene NPPB and breast carcinoma.